Journal Logo

August 2020 - Volume 30 - Issue 4
pp: 325-428

Basic science

Clinical research

The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma

Kowalik, Artur; Jurkowska, Monika; Mierzejewska, Ewa; More

Melanoma Research. 30(4):348-357, August 2020.

Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases

Holtkamp, Lodewijka H.J.; Chakera, Annette H.; Fung, Sebastian; More

Melanoma Research. 30(4):358-363, August 2020.

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

Vera Aguilera, Jesus; Paludo, Jonas; McWilliams, Robert R.; More

Melanoma Research. 30(4):364-375, August 2020.


Basic science

Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec

Audrey-Bayan, Claire; Trager, Megan H.; Gartrell-Corrado, Robyn D.; More

Melanoma Research. 30(4):410-415, August 2020.

Clinical science